Delivery Order SPE2DB25D3003-SPE2DB25FPWYH
Award Date 8/12/25
Potential Completion Date 8/13/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $9,063.60 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) 40 mg/0.4 mL prefilled pens. The contract was competitively awarded without set-aside provisions and carries a firm fixed price structure with an ultimate completion date of August 5, 2025. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL. This non-competitive, firm fixed-price delivery order is valued at $116,800.12 and is due for completion by August 5, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,510.60 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) prefilled pens at 40 mg/0.4 mL on June 3, 2025, with performance in Conshohocken, Pennsylvania. This is a firm fixed price, non-set-aside contract with a completion date of June 4, 2025. The delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of HUMIRA (adalimumab) Pen 40 mg/0.4 mL, a biologic immunosuppressant medication. This firm fixed-price delivery order, valued at $57,804.94, represents a non-competitive award under a larger contract vehicle and is scheduled for completion by August 8, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency awarded a $3,162.25 delivery order contract to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL pharmaceutical supplies. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 8, 2025. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. No set-aside designation was applied to this award, indicating...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,745.11 by the Defense Logistics Agency on August 27, 2025, with completion scheduled for August 28, 2025. The contract, awarded without set-aside designation through competitive procurement, covers the supply of Humira (adalimumab) prefilled pen injections at 40 mg/0.4 mL dosage. The delivery order was issued under a firm fixed-price arrangement...
- The Defense Logistics Agency awarded a delivery order valued at $3,021.20 to AmerisourceBergen Drug Corp for the supply of HUMIRA (adalimumab) prefilled pens containing 40 mg/0.4 mL. This is a firm fixed-price contract with no set-aside designation, executed on June 3, 2025, with an ultimate completion date of June 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 12, 2025, for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL, a biologic pharmaceutical used to treat autoimmune conditions. This competitively awarded, non-set-aside delivery order carries a ceiling value of $11,239.33 under a firm fixed-price arrangement, with an ultimate completion date of September 15, 2025. The contract is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-aligned federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of HUMIRA (Adalimumab) Pen 40 mg/0.4 mL prefilled pens, with a ceiling value of $1,205.75. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by June 20, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a $3,898.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) pre-filled pens at 40 mg/0.4 mL on September 15, 2025, with an ultimate completion date of September 16, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The IDC serves...